Narrow complex tachycardia resident survival guide: Difference between revisions
(/* Acute management of Hemodynamically Stable Narrow QRS Regular Tachycadia{{Cite web | last = | first = | title = ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary | url = http://circ.ahajou...) |
No edit summary |
||
Line 16: | Line 16: | ||
==Initial Diagnosis== | ==Initial Diagnosis== | ||
Shown below is an algorithm | |||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | | | | | | | | A01 | | | | | | | |A01= Charcterize the symptoms}} | {{familytree | | | | | | | | A01 | | | | | | | |A01= Charcterize the symptoms}} | ||
Line 68: | Line 69: | ||
{{familytree |L|~| K01 | | K02 | | | | | | | | | | K01=[[AVNRT]]|K02=[[AVRT]]<br>[[AVNRT]]<br>Atrial tachycardia}} | {{familytree |L|~| K01 | | K02 | | | | | | | | | | K01=[[AVNRT]]|K02=[[AVRT]]<br>[[AVNRT]]<br>Atrial tachycardia}} | ||
{{familytree/end}} | {{familytree/end}} | ||
† Echocardiographic examination is required in patients with documented sustained [[supraventricular tachycardia]] to rule out structural heart disease. | † Echocardiographic examination is required in patients with documented sustained [[supraventricular tachycardia]] to rule out structural heart disease.<br> | ||
Patients with focal junctional tachycardia may mimic the pattern of slow-fast [[AVNRT]] and may show AV dissociation and/or marked irregularity in the junctional rate.<br>AV | * Patients with focal junctional tachycardia may mimic the pattern of slow-fast [[AVNRT]] and may show AV dissociation and/or marked irregularity in the junctional rate.<br> | ||
<span style="font-size:85%">'''AV''': Atrioventricular; '''[[AVNRT]]''': [[Atrioventricular nodal reciprocating tachycardia]]; '''[[MAT]]''': [[Multifocal atrial tachycardia]]; '''ms''': miliseconds; '''PJRT''': Permanent form of junctional reciprocating tachycardia; '''QRS''': Ventricular activation on ECG</span> <br> | |||
''Algorithm based on the 2003 ACC/AHA/ESC guidelines for the management of supraventricular arrhythmias.''<ref name="circ.ahajournals.org">{{Cite web | last = | first = | title = ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary | url = http://circ.ahajournals.org/content/108/15/1871 | publisher = | date = | accessdate = 15 August 2013 }}</ref> | ''Algorithm based on the 2003 ACC/AHA/ESC guidelines for the management of supraventricular arrhythmias.''<ref name="circ.ahajournals.org">{{Cite web | last = | first = | title = ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary | url = http://circ.ahajournals.org/content/108/15/1871 | publisher = | date = | accessdate = 15 August 2013 }}</ref> | ||
Revision as of 22:52, 2 March 2014
File:Critical Pathways.gif |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hilda Mahmoudi M.D., M.P.H.[2]
Definition
Narrow complex tachycardia is defined as a rhythm with heart rate > 100 beats per minute and a QRS complex duration < 120 milliseconds.
Causes
Life Threatening Causes
Life-threatening causes include conditions which result in death or permanent disability within 24 hours if left untreated.
Common Causes
Initial Diagnosis
Shown below is an algorithm
Charcterize the symptoms | |||||||||||||||||||||||||||||||||||||||
Examine the patient | |||||||||||||||||||||||||||||||||||||||
Order tests
❑ 24 hour holter monitor
❑ Loop recorder
❑ Trans-esophageal atrial recordings
| |||||||||||||||||||||||||||||||||||||||
Undocumented arrhythmia | Documented arrhythmia | ||||||||||||||||||||||||||||||||||||||
❑ History suggests extra premature beats. ❑ Surface ECG is normal. | ❑ History suggests paroxysmal arrhythmia. ❑ 12 lead ECG doesn't suggest any mechanism for arrhythmia. | Stable patient | Unstable patient | ||||||||||||||||||||||||||||||||||||
❑ Refer for an invasive electrophysiological study AND/OR ❑ Catheter ablation ❑ Teach vagal maneuvers to patients. ❑ Consider beta blocking agent. | ❑ Treat according to the type of arrhythmia. | ❑ Obtain a monitor strip form the defibrillator. ❑ Immediate direct current cardioversion. | |||||||||||||||||||||||||||||||||||||
Management
Differential Diagnosis for Narrow QRS Tachycardia[1]
Narrow QRS tachycardia (QRS duration less than 120 ms) | |||||||||||||||||||||||||||||||||||||||||||
Regular rhythm | Irregular rhythm | ||||||||||||||||||||||||||||||||||||||||||
P waves present? | Atrial fibrillation Atrial tachycardia/flutter with variable AV conduction MAT | ||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||
Atrial rate greater than ventricular rate? | |||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||
Atrial flutter or atrial tachycardia | Analyze RP interval | ||||||||||||||||||||||||||||||||||||||||||
Short (RP shorter than PR) | Long (RP longer than PR) | ||||||||||||||||||||||||||||||||||||||||||
RP shorter than 70 ms | RP longer than 70 ms | Atrial tachycardia PJRT Atypical AVNRT | |||||||||||||||||||||||||||||||||||||||||
AVNRT | AVRT AVNRT Atrial tachycardia | ||||||||||||||||||||||||||||||||||||||||||
† Echocardiographic examination is required in patients with documented sustained supraventricular tachycardia to rule out structural heart disease.
- Patients with focal junctional tachycardia may mimic the pattern of slow-fast AVNRT and may show AV dissociation and/or marked irregularity in the junctional rate.
AV: Atrioventricular; AVNRT: Atrioventricular nodal reciprocating tachycardia; MAT: Multifocal atrial tachycardia; ms: miliseconds; PJRT: Permanent form of junctional reciprocating tachycardia; QRS: Ventricular activation on ECG
Algorithm based on the 2003 ACC/AHA/ESC guidelines for the management of supraventricular arrhythmias.[1]
Differential Diagnosis of Narrow Complex Tachycardias According to Adenosine Response.[1]
Regular narrow QRS complex tachycardia | |||||||||||||||||||||||||||||||||||||||||||||||
IV adenosine | |||||||||||||||||||||||||||||||||||||||||||||||
No change in rate | Gradual slowing then reacceleration of rate | Sudden termination | Persisting atrial tachycardia with transient high-grade AV block | ||||||||||||||||||||||||||||||||||||||||||||
Inadequate dose/delivery Condiser VT (fascicular or hight septal origin) | Sinus tachycardia Focal AT Nonparoxysmal junctional tachycardia | AVNRT AVRT Sinus node re-entry Focal AT | Atrial flutter AT | ||||||||||||||||||||||||||||||||||||||||||||
AT indicates atrial tachycardia; AV, atrioventricular; AVNRT, atrioventricular nodal reciprocating tachycardia; AVRT, atrioventricular reciprocating tachycardia; IV, intravenous; QRS, ventricular activation on ECG; VT, ventricular tachycardia.
Algorithm based on the 2003 ACC/AHA/ESC guidelines for the management of supraventricular arrhythmias.[1]
Acute management of Hemodynamically Stable Narrow QRS Regular Tachycadia[1]
Hemodynamically stable regular tachycardia | |||||||||||||||||||||||||||||||||||||||||||
❑ Confirm diagnosis of narrow QRS complex tachycardia | |||||||||||||||||||||||||||||||||||||||||||
❑ Perform vagal maneuvers
❑ Administer IV adenosine† | |||||||||||||||||||||||||||||||||||||||||||
Arrhythmia terminated | Persistent tachycardia with AV block | ||||||||||||||||||||||||||||||||||||||||||
❑ Administer IV ibutilide‡ PLUS ❑ AV-nodal-blocking agent ❑ Overdrive pacing/DC cardioversion, and/or ❑ Rate control | |||||||||||||||||||||||||||||||||||||||||||
†Adenosine should be used with caution in patients with severe coronary artery disease and may produce
AF, which may result in rapid ventricular rates for patients with pre-excitation.
‡ Ibutilide is especially effective for patients with atrial flutter but should not be used in patients with EF less than 30% due to increased risk of polymorphic VT. AF indicates atrial fibrillation; AV, atrioventricular; BBB, bundle-branch block; DC, direct current; IV, intravenous; LV, left ventricle; QRS, ventricular activation on ECG; SVT, supraventricular tachycardia; VT, ventricular tachycardia.
Algorithm based on the 2003 ACC/AHA/ESC guidelines for the management of supraventricular arrhythmias.[1]
Do's
- Refer narrow complex tachycardic patients with following characteristics to a cardiac arrhythmia specialist:
- Patients with drug resistance
- Patients with intolerance to drugs
- Patients who do not want any drug therapy.
- Patients with severe symptoms such as syncope and dyspnoea during palpitations.
- Refer all the patients with Wolff-Parkinson-White syndrome (WPW syndrome) to a cardiac arrhythmia specialist.
Don'ts
- Do not perform esophageal stimulation if an invasive electrophysiological investigation is planned.